Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.700
-0.160 (-5.59%)
Dec 20, 2024, 4:00 PM EST - Market closed
Skye Bioscience Employees
Skye Bioscience had 11 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,930,961
Market Cap
81.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
23andMe Holding Co. | 582 |
bluebird bio | 375 |
Karyopharm Therapeutics | 325 |
EDAP TMS | 307 |
Rani Therapeutics Holdings | 140 |
Adlai Nortye | 127 |
Theratechnologies | 103 |
Aadi Bioscience | 89 |
SKYE News
- 2 days ago - Skye Bioscience to Present at J.P. Morgan Healthcare Conference - GlobeNewsWire
- 11 days ago - Skye Bioscience: Nimacimab Targets Safer Weight Loss, Speculative Buy - Seeking Alpha
- 5 weeks ago - Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor - GlobeNewsWire
- 6 weeks ago - Skye Bioscience, Inc. (SKYE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 7 weeks ago - Skye Bioscience to Announce Third Quarter 2024 Results - GlobeNewsWire
- 2 months ago - Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences - GlobeNewsWire
- 2 months ago - 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn't Ignore - Benzinga